β-Blocker use is associated with a higher relapse risk of inflammatory bowel disease: a Dutch retrospective case–control study
Rose Willemze(Amsterdam University Medical Centers), Wouter J. de Jonge(University of Bonn), Tinka Bakker(Amsterdam University Medical Centers), Cyriel Y. Ponsioen(Amsterdam UMC Location University of Amsterdam), Maria Pippias(North Bristol NHS Trust)
Cited by 27
Related Papers
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
|Nature Immunology|2005|1.1k
The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
|British Journal of Pharmacology|2007|634
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
|Nature Genetics|2013|398
Neuroimmune mechanisms in postoperative ileus
|Gut|2009|362